ClinicalTrials.gg

Program

platelet rich plasma

Also written as “Platelet-Rich Plasma (PRP) Injections”, “[PRP] platelet rich plasma” and “Autologous PRP Gel and PRP Injection”.

Its studies are mostly in Osteoarthritis · Alopecia · Osteoarthritis, Knee · Diphtheria · Pain, led by 8 companies.

Furthest: phase 4, since Mar 15, 20178 company-led studies, 3 open or runningNext primary completion: Aug 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Bioheart10 open or runningphase 1since Mar 15, 2017Mar 15, 2017none ahead
Exactech10 open or runningphase 4since Jan 20, 2009Jan 20, 2009none ahead
Integrant Pty11 open or runningphase 3since Mar 26, 2025Mar 26, 2025Aug 2027phase 3 · NCT06907121
Kimberly Meathrel11 open or runningearly phase 1since Jul 28, 2026Jul 28, 2026Dec 30, 2027early phase 1 · NCT07739147
PT. Prodia Stem Cell Indonesia11 open or runningphase 2since Feb 17, 2026Feb 17, 2026none ahead
QC Kinetix10 open or runningphase 2since Feb 6, 2023Feb 6, 2023none ahead
TotipotentRX Cell Therapy Pvt.10 open or runningphase 1since Jan 4, 2017Jan 4, 2017none ahead
Zimmer Biomet10 open or runningno phasesince Sep 22, 2008Sep 22, 2008none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 22, 2008First study: no phase study in PainNew to Zimmer BiometZimmer Biomet · NCT00757289 · 106 enrolled · Netherlands
  2. Jan 20, 2009Exactech's first study: phase 4 study in OsteoarthritisNew to ExactechExactech · NCT00826098 · 70 enrolled · United States
  3. Jan 4, 2017TotipotentRX Cell Therapy Pvt.'s first study: phase 1 study in Chronic UlcerNew to TotipotentRX Cell Therapy Pvt.TotipotentRX Cell Therapy Pvt. · NCT03026855 · 24 enrolled · India
  4. Mar 15, 2017Bioheart's first study: phase 1 study in OsteoarthritisNew to BioheartBioheart · NCT03089762 · 10 enrolled
  5. Feb 6, 2023QC Kinetix's first study: phase 2 study in Osteoarthritis, KneeNew to QC KinetixQC Kinetix · NCT05742763 · United States
  6. Mar 26, 2025Integrant Pty's first study: phase 3 study in Arthritis AnkleNew to Integrant PtyIntegrant Pty · NCT06907121 · 192 planned · Australia
  7. Feb 17, 2026PT. Prodia Stem Cell Indonesia's first study: phase 2 study in AlopeciaNew to PT. Prodia Stem Cell IndonesiaPT. Prodia Stem Cell Indonesia · NCT07429253 · 40 planned · Indonesia
  8. Jul 28, 2026Kimberly Meathrel's first study: early phase 1 study in AlopeciaNew to Kimberly MeathrelKimberly Meathrel · NCT07739147 · 30 planned

Ahead

  1. Aug 2027Primary completion: phase 3 study in Arthritis AnkleIntegrant Pty · NCT06907121
  2. Dec 30, 2027Primary completion: early phase 1 study in AlopeciaKimberly Meathrel · NCT07739147

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 8 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07739147AlopeciaEarly 1Not yet recruitingKimberly MeathrelDec 30, 202730
NCT07429253Alopecia · Indonesia2RecruitingPT. Prodia Stem Cell IndonesiaJun 30, 202640
NCT06907121Arthritis Ankle · Australia3Not yet recruitingIntegrant PtyAug 2027192
NCT05742763Osteoarthritis, Knee · United States2WithdrawnQC KinetixOct 7, 20240
NCT03089762Osteoarthritis1CompletedBioheartDec 30, 201410
NCT03026855Chronic Ulcer · India1CompletedTotipotentRX Cell Therapy Pvt.Apr 201624
NCT00826098Osteoarthritis · United States4CompletedExactechJun 201170
NCT00757289Pain · Netherlands–CompletedZimmer BiometJan 2008106

How it is read

Names in the registry

  • “Platelet-Rich Plasma (PRP) Injections”, 2 entries
  • “[PRP] platelet rich plasma”, 2 entries
  • “Autologous PRP Gel and PRP Injection”, 2 entries
  • “Intra-Articular Injection of Growth Hormone and Platelet-Rich Plasma”, 1 entry
  • “Ibuprofen and PRP”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.